top of page
Search


Psychedelic-Assisted Therapies Enter Addiction Treatment Conversation
Psilocybin is not FDA-approved to treat substance use disorders. The findings below come from clinical research and do not support self-administering psilocybin or other psychedelics. Any use of these substances for treatment should occur only under a healthcare provider's guidance and as part of an appropriate medical protocol. Psilocybin has recently been evaluated in clinical trials as a possible treatment for several substance use disorders, including smoking cessation an
4 days ago


Polysubstance Use Disorders Common Among U.S. Adults
Early Substance Use Also Linked to Higher Rates of Polysubstance Use Disorders Despite slight decreases in overall overdose deaths in recent years, deaths involving multiple drugs have risen over time. A study published in Molecular Psychiatry examined the prevalence of U.S. adults who had multiple substance use disorders (SUDs)––also known as a polysubstance use disorder––and whether the age at which they first used substances was associated with the number of disorders they
Nov 5


Cannabis and Mental Health Treatment: What Does the Research Show?
Researchers conducted a review of the scientific literature to determine if using cannabis helped treat mental health problems. They identified 15 articles, divided by the type of mental health condition and form of cannabis used as a treatment. Overall, they found: No clear benefits: Evidence is too limited and uncertain to support cannabis as a treatment for conditions like post‑traumatic stress disorder, anxiety, depression, or ADHD. Some possible small benefit: A few stud
Nov 5


Does Cannabis Help or Hurt Sleep? Insights from a Long-Term Study
Many people use cannabis believing it helps them sleep. Researchers sought to understand whether cannabis (marijuana) use is linked to sleep quality in middle-aged adults. Researchers followed participants in a long-running U.S. health study for up to 35 years and examined both: Lifetime cannabis use (how much cannabis people had used over many years) Recent cannabis use (use within the past 30 days) To measure sleep, they used: A wearable device that tracked sleep objectivel
Nov 4


Alcohol Continues to Lead U.S. Treatment Admissions, Followed by Methamphetamine and Synthetic Opioids
A recent report from the Substance Abuse and Mental Health Services Administration (SAMHSA) provides a comprehensive look at substance use disorder (SUD) treatment across the United States, including who is entering treatment, what substances are most commonly involved, and what services are being utilized. Drawing on data from the Treatment Episode Data Set (TEDS), the annual report captures admissions and discharges among individuals ages 12 and older receiving treatment at
Nov 3


New Review Examines Psychosocial Treatments for Substance Use Disorder
Effective treatment for substance use disorder (SUD) can include counseling and other psychosocial approaches, such as Cognitive Behavioral Therapy (CBT) and Contingency Management (CM). These therapies can help people build coping skills, manage cravings, strengthen relationships, and work toward their own recovery goals. A systematic review published in Clinical Psychology & Psychotherapy examined 64 randomized controlled trials published between 2021 and 2025. The studies
Nov 2


Semaglutide Shows Promise as Potential New Treatment for Alcohol Use Disorder
Semaglutide, a GLP-1 receptor agonist widely used to treat obesity, has shown promise in treating Alcohol Use Disorder (AUD). Researchers in Copenhagen, Denmark, conducted a study with individuals seeking treatment for AUD who also had comorbid obesity. Participants were randomly assigned to receive either semaglutide or a placebo, alongside cognitive behavioral therapy. Those who received semaglutide achieved a 41% reduction in heavy drinking days—an outcome nearly 14% great
Nov 2


Researchers Make Progress Toward a Pain-Relieving Medication with Minimal Risk of Addiction
Developing effective pain-relieving medication with a low risk of addiction has long been a significant challenge in medical research. This year, a team of researchers at the National Institutes of Health (NIH) identified a novel, highly potent synthetic opioid compound that demonstrates substantial pain reduction without the classic hallmarks of addiction. The research team, led by scientists at the National Institute on Drug Abuse (NIDA), revisited an understudied class of
Oct 27


Brain Scans Reveal Why Stress Makes It Hard to Quit Smoking
A large body of research identifies the insula as a critical brain region involved in maintaining tobacco use disorder (TUD). The insula integrates emotion, cognition, and distress identification, linking distress awareness to cognitive control networks. Among daily smokers, distress triggers cravings and decreases the capacity to tolerate negative emotions, a key predictor of long-term cessation success. In this study, researchers investigated whether individual differences
Oct 27


Study Finds Buprenorphine May Reduce Cannabis Use in Patients Treated for Opioid Use Disorder
Most people with a substance use disorder concurrently use multiple drugs. Prior research estimates that approximately a quarter of individuals with an opioid use disorder (OUD) also use cannabis. While both buprenorphine and naltrexone are FDA-approved medications for the treatment of OUD, their specific impact on cannabis use has historically remained unknown. To explore this relationship, researchers sought to determine whether either extended-release naltrexone or subling
Oct 26


School- and Family-based Intervention Reduced Substance Use Among Rural and Tribal Youth
Rural and American Indian/Alaska Native (AI/AN) communities continue to experience some of the most severe impacts of the overdose crisis. During the fourth wave of the U.S. overdose crisis beginning in 2022, AI/AN youth and young adults—particularly those aged 15 to 34—experienced the highest overdose death rates of any racial or ethnic group. These disparities underscore the urgent need for prevention strategies that are both effective and responsive to community context. F
Oct 26


The Body’s Nerve Superhighway: Could Vagus Nerve Stimulation Help Treat Addiction?
The vagus nerve is a massive, two-way superhighway connecting your brain to all your major internal organs. It controls the body’s automatic (parasympathetic) nervous system, tracking breathing, heart rate, pain, temperature, and organ health. The brain then uses this data to regulate stress levels, mood, and inflammation. Vagus nerve stimulation (VNS) is a treatment that sends mild electrical signals up the vagus nerve. By stimulating this pathway, VNS directly alters the br
Oct 26


Study Finds Access to Medications to Treat Alcohol Use Disorder Hits a Plateau
Alcohol use disorder (AUD) is widely prevalent, yet evidence-based medications for alcohol use disorder (MAUD)—such as naltrexone, acamprosate, and disulfiram—remain significantly underutilized. To understand how accessibility has shifted over time, a cross-sectional study published in JAMA Network Open evaluated the national availability of MAUD within substance use disorder treatment facilities. Key Findings A Plateau in Growth: The proportion of treatment facilities offeri
Oct 16


New Study Reveals Best Way to Help Newborns Recovering from Opioid Exposure
A new multi-hospital study shows that a flexible, symptom-based approach helps newborns recovering from prenatal opioid exposure go home sooner. When babies are exposed to opioids in the womb, they are at high risk for Neonatal Opioid Withdrawal Syndrome (NOWS). These infants usually experience sharp withdrawal symptoms during their first week of life. While nonpharmacological care and comfort measures—such as quiet rooms and swaddling—are typically the first line of defense,
Oct 13


What Cannabis Legalization May Mean for Young Teens’ Views About Cannabis
As cannabis laws continue to change across the United States, researchers are working to understand how these changes may shape young people’s beliefs about cannabis. This study, published in Drug and Alcohol Dependence, looked at whether early adolescents—about 12 years old on average—had different expectations about cannabis depending on whether they lived in a state with no cannabis legalization, medical cannabis legalization, or recreational cannabis legalization. The res
Aug 6


U.S. Overdose Deaths Are Declining, Just Not for Everyone
This article explains that drug overdose deaths in the United States began to fall steadily around August 2023 after many years of increases, especially during the fentanyl era. This is encouraging news, but the decline has not happened evenly across the country, across all drug types, or across all groups of people. In the study, published in JAMA Network Open, researchers examined 800,645 drug overdose deaths between January 2015 and October 2024 using data from the Nationa
Aug 4


2025 National Survey Shows Declines in Substance Use Disorders, while Significant Treatment Gaps Remain
The Substance Abuse and Mental Health Services Administration (SAMHSA) released findings from the 2025 National Survey on Drug Use and Health (NSDUH), providing the latest national data on substance use, mental health, treatment, and recovery in the United States. In 2025, 44.6 million people ages 12 or older—15.3% of the U.S. population—had a substance use disorder (SUD). This total included 25.7 million people with alcohol use disorder (AUD), 26 million with drug use disor
Jul 28


1 in 4 U.S. Adults Don’t Recognize Addiction as a Health Condition
New Addiction Policy Forum and Gallup Study Released Findings from a nationally representative study show that nearly 1 in 4 U.S. adults (23%) either disagree or do not know that addiction is a health condition. Individuals who did not recognize addiction as a health condition were significantly less likely to believe substance use disorders (SUDs) are treatable by healthcare professionals, that early intervention works, or that medications are effective treatments to treat a
Jun 1


Alcohol Remains the Primary Driver of Treatment Admissions in the U.S., followed by Methamphetamines and Heroin
A recent report from the Substance Abuse and Mental Health Services Administration (SAMHSA) provides a comprehensive look at substance use disorder (SUD) treatment across the United States, including who is entering treatment, what substances are most commonly involved, and what services are being utilized. Drawing on data from the Treatment Episode Data Set (TEDS), the annual report captures admissions and discharges among individuals ages 12 and older receiving treatment a
Apr 7


Study Finds Association Between Chronic Cannabis Use and Cardiovascular Dysfunction
In a study published in JAMA Cardiology, researchers found chronic cannabis use—whether through smoking or THC-infused edibles—is associated with impaired vascular function, even among young and otherwise healthy adults. Healthy vascular function allows blood vessels to dilate properly, deliver oxygen efficiently, and help regulate key processes within the circulatory system. When vascular function is impaired, blood vessels are less able to expand, which can reduce blood flo
Mar 30
bottom of page
